INTRODUCTION
Epigenetic modifications, apart from their well-known role in cell differentiation and cancer pathogenesis, are increasingly reported to be crucial in regulation of the immune responses. The involvement of epigenetic modifications during primary immune responses is emerging, with much attention focused on the T and B lymphocyte differentiation [reviewed in (1) ]. In contrast, relatively few studies focus on the role of epigenetic modifications to innate immune cells during primary infection. Innate immune cell epigenetic modifications may be important axes in controlling initial immune polarization in vitro (2) and effector immune responses of myeloid cells in vivo (3) . In parallel, the mainstream understanding of immunological memory has expanded by recent demonstration of innate immune cells exhibiting immunological memory-type responses, which enhance protection against reinfection (4) (5) (6) (7) . This phenomenon of innate immunological memory (trained immunity) was shown to be mediated by specific changes to epigenetic modifications and thereby the metabolic and transcriptional programs of innate effector cells such as macrophages, monocytes, and natural killer cells (8) (9) (10) . However, it remains unknown whether epigenetic modifications to innate cells, particularly dendritic cells (DCs), could be important in not only responding to but also shaping the immune responses to primary infections in vivo.
Myeloid cells demonstrate diverse functional capabilities and, apart from acting as antimicrobial effector cells, are the major subset responsible for antigen processing and generation of antigen-specific effector T cells (11, 12) . Their functions are modulated by the local inflammatory environment, which dictates myeloid cell classical (DC1/M1) or alternative (DC2/M2) polarization profiles. Classically activated (DC1/M1-like) myeloid cells are induced via STAT1 (signal transducer and activator of transcription 1), IRF1 (interferon regulatory factor 1), and/or IRF5 pathways, triggered by stimulation of cells with lipopolysaccharide (LPS), interferon- (IFN), and/or granulocyte-macrophage colony-stimulating factor (GM-CSF). These cells induce inducible nitric oxide synthase (iNOS) and a variety of important proinflammatory factors. Conversely, alternatively activated (DC2/M2-like) cells develop in the environment of interleukin-4 (IL-4), IL-10, or M-CSF and are known to activate Stat3/6, Klf2/4, and IRF3/4 pathways. A DC2 phenotype is characterized by arginase1dependent metabolism of arginine and is associated with secretion of a spectrum of anti-inflammatory factors. The DC1 phenotype is essential for priming T helper 1 (T H 1) responses, required for killing of intracellular bacteria, such as Mycobacterium tuberculosis, and other persistent intracellular parasites, including fungi such as Cryptococcus neoformans (C. neo) (13) . DCs also actively contribute to T cell restimulation in the infection sites and serve as effector cells destroying microorganisms (14) (15) (16) , and thus, DC polarization may affect antimicrobial defenses at multiple levels.
Myeloid cell polarization is thought to be highly plastic in response to changes in stimulation by different group of mediators (17) . On the other hand, M2-polarized macrophages were shown to display unique histone modification signature, suggesting that some level of transcriptional stability is present in these cells (18) . If DC could acquire this DC1/DC2 program stabilization during infections, one would expect this to affect T H 1/T H 2 priming and/or possibly influence the long-term maintenance of the polarized T H phenotype. However, DC1/DC2 polarization plasticity versus stability has not been investigated, and thus, it remains unknown how transcriptional stability of DC polarization program could affect DC functions during immune responses.
Cryptococcosis is a relevant example of highly fatal and persistent infection, which requires stable T H 1/T H 17 immune response for clearance, in contrast with T H 2 responses that support the development of chronic infection and latency (19) (20) (21) . Studies by our group demonstrated that manipulation of one of the central inflammatory mediator, tumor necrosis factor  (TNF), deranges protective T H 1 responses to C. neo (7) . Consistent with our models, epidemiology studies show that cryptococcosis is increasingly seen in patients undergoing anti-TNF antibody therapies (22) (23) (24) .
Here, we show that TNF induces a state of DC1 phenotypic memory or programming, which is required for T H 1/T H 17 immune protection during cryptococcosis. Mechanistically, our study overwhelmingly suggests that TNF signaling facilitates methylation of histone 3 lysine 4 (H3K4) at crucial DC1 gene promoter regions and affects expression and function of mixed-lineage leukemia protein-1 (MLL1) methyltransferase activity. Our study demonstrates that this programming of DC can translate into the fate of adaptive immunity and that TNF is the central mediator required to trigger these effects.
RESULTS

TNF results in prolonged stable DC1 gene expression and DC2 gene suppression
Acute-phase production of TNF is critical for control and clearance of the model invasive fungal infection (IFI) C. neo (7) . CBA/J mice with intact TNF signaling (control) clear C. neo within 28 days postinfection (dpi), but those that were TNF depleted (anti-TNF) with a single injection of TNF-blocking antibody at the time of infection do not clear C. neo ( fig. S1A ). We show that control mice with intact TNF signaling induce sustained classical activation of DCs (DC1) and strongly polarized T H 1/T H 17 protective immunity upon infection with C. neo (fig. S1 , B and C) (7) . The absence of TNF results in a suppressed DC1 signature [iNOS, IL-12b, and major histocompatibility complex II (MHCII)]; up-regulation of DC2 markers (Fizz1, IL-13, and CD206) in pulmonary DC; and nonprotective, dysregulated immune responses with marked up-regulation of T H 2 hallmarks ( fig. S1 , B and C) (7) . While the recovery of serum TNF levels in anti-TNFtreated mice begins to occur around 14 dpi (fig. S1D), this does not result in a recovery of DC1 phenotype in the infected anti-TNF mice or restoration of fungal clearance (fig. S1A) (25, 26) .
Our in vivo data linked TNF priming with the induction of long-lasting DC1 programming and preventing DC2 skewing during C. neo infection. To study this yet-unknown mechanism of acute priming with TNF and its possible role in generating DC1 and DC1-type persistence throughout infection, we conducted a series of studies in vitro. First, we demonstrated plasticity of DC by challenging DC1 generated from bone marrow (BMDCs) treated with IFN with a DC2-driving cytokine, IL-4 (see fig. S2A for schematic). DCs treated with IFN had high expression of DC1 markers over baseline [all quantitative polymerase chain reactions (qPCRs) were performed relative to untreated DCs], which was suppressed by challenge with IL-4 at both the mRNA ( Fig. 1 , A to C) and protein ( Fig. 1 , D to F) levels. While TNF on its own did not induce DC1 activation, DC1 pretreated with TNF during their initial IFNinduced polarization resisted subsequent IL-4-mediated change to DC2, maintaining robust DC1 gene expression at both the mRNA ( Fig. 1 , A to C) and protein ( Fig. 1 , D to F) levels. Similarly, DC1s challenged with IL-4 up-regulated DC2 markers at both the mRNA ( Fig. 1 , G to I) and protein ( Fig. 1 , J to L) levels, showing strong DC1-DC2 plasticity; however, pretreatment with TNF prevented DC2 magnitude up-regulation of these factors in an IL-4 environment. Fizz1 and CD206 mRNA increased slightly but significantly with IL-4 treatment; however, the levels induced are still at (Fizz1) or below (CD206) the level seen in nonstabilized DC1 with a P value of <0.001. No DCs from any culture conditions made an appreciable amount of TNF when assessed at the mRNA level ( fig. S2B ). We performed these experiments using both 24-and 48-hour incubation periods (fig. S2, C and D) for programming and challenge, achieving similar results at 48 hours. Together, these data demonstrate that TNF stimulation during the initial DC1 activation resulted in a stabilized DC1 phenotype (TNF-programmed DC1) capable of sustaining a DC1 phenotype in a DC2-skewing environment.
To determine the DC1 specificity of TNF-mediated effect, we also assessed whether TNF could stabilize DC2 polarization. DC2s were generated using IL-4 in the absence or presence of TNF with a subsequent challenge with IFN. Both untreated and TNF-treated DC2s challenged with IFN up-regulated DC1 markers ( fig. S2D ) and down-regulated DC2 markers ( fig. S2E ), indicating that TNF did not promote DC2-type stabilization and TNF-treated DC2 did not resist changes to DC1 phenotype. Thus, TNF programming exclusively supports DC1 stabilization but does not alter plasticity of DC2 phenotype.
TNF signals through two canonical receptors, TNFRI and TNFRII, both of which are expressed on DCs (27) (28) (29) . We tested which receptor was required for the TNF-associated stabilization of DC1 programming by inhibiting the receptors with blocking antibodies individually and in combination during the programming phase. When each receptor was blocked individually ( fig. S3 , A to C), DC1 and DC2 genes partially recovered plasticity. DC1 and DC2 gene plasticity completely recovered only when both TNFRI and TNFRII were simultaneously blocked ( fig. S3D ), suggesting that signaling through both receptors contributes to TNF-mediated DC1 programming.
TNF promotes DC1 stability and T H 1 priming in immunomodulatory environments
We next sought to determine whether TNF could promote DC1 stability in the presence of C. neo antigen, which is known to exhibit strong DC2 skewing capacity (30) (31) (32) . Heat-killed C. neo (HKC) suppressed iNOS in all types of cytokine treatments relative to non-HKCtreated samples ( Fig. 2 , A to C). However, TNF-programmed DCs maintained higher expression of iNOS ( Fig. 2A ) and IL-12b ( Fig. 2B ) and lower expression of IL-13 ( Fig. 2C ) relative to their HKC-treated DC2 counterparts. However, the cytokine patterns of DCs treated with IFN alone in the presence of HKC resembled HKC-treated DC2: They maintained low iNOS and IL-12b expression and high IL-13 expression. Thus, C. neo antigen-mediated DC2 skewing can compromise DC1 activation, but the presence of TNF during activation can intercept this immunomodulation to stabilize the DC1 programming.
To test whether TNF-programmed DC1s were functional DC1s in immunomodulatory environments, we next asked whether TNFprogrammed DC1 could prime T H 1 responses in the presence of C. neo antigen. DC1 cocultured with CD4 T cells over 5 days triggered increased numbers of activated CD44 hi CD62L lo CD4 T cells, robust T cell IFN production, and low T cell IL-5 production ( Fig. 2 , D to F). The addition of HKC to DC1-CD4 T cell cocultures resulted in diminished abundance of CD44 hi CD62L lo CD4 T cells, lower T cell IFN production, and higher T cell IL-5 production compared to Note that there were no significant differences between HKC-treated No TNF samples regardless of IL-4 challenge. n = 18 from three separate matched experiments. (D to F) BMDCs generated from OT-II mice were stimulated to become DC1 in the presence (TNF) or absence (No TNF) of TNF, and HKC were incubated with naïve splenic CD4 T cells and OVA peptide for 5 days. (D) CD4 T cell activation (CD44 hi CD62L lo ) and frequency of (E) IFN-producing and (F) IL-5-producing T cells were assessed by flow cytometry as seen in representative flow plots and cumulative data. n = 6. *P < 0.05, **P < 0.01, and ***P < 0.001 between the indicated sample and HKC-treated No TNF sample. (G and H) Magnetically sorted CD11c + cells isolated from mouse lung at 7 and 14 dpi and qPCR performed for iNOS (G) and IL-12b (H). n = 8 per group from two separate matched experiments conducted months apart and from different cages. *P < 0.05, **P < 0.01, and ***P < 0.001 between the indicated samples.
HKC-free conditions. However, in the presence and absence of HKC, TNF-programmed DC1s cocultured with CD4 T cells had uniformly increased CD44 hi CD62L lo CD4 T cells, robust T cell IFN production, and low T cell IL-5 production ( Fig. 2 , D to F). Thus, TNF stabilized DC1 programming and T H 1 priming functionality, especially helping to overcome the immunomodulatory environment of cryptococcal antigen.
TNF stabilizes DC1 programming in vivo and induces major changes in the epigenetic landscape of H3K4me3 histone modification
We next tested whether TNF could induce sustained DC1 polarization in our C. neo mouse model of IFI. Throughout the course of infection, CD11c + cells from the lungs of C. neo-infected control mice had robust induction of iNOS and IL-12b at the mRNA level ( Fig. 2 , G and H), indicative of DC1 programming, in contrast to CD11c + cells from the lungs of infected anti-TNF mice. To verify DC1 programming at the protein level, flow-gated CD11b + /CD11c + DCs from infected control mice also had high MHCII and CD86 expression, while DCs from infected anti-TNF mice had lower expression of both MHCII and CD86 ( fig. S4A ); furthermore, infected control mice had high levels of IL-12p70 in the serum, while very low amounts of IL-12p70 were found in the serum of infected anti-TNF-treated mice throughout the infection ( fig. S4B ). Early TNF is thus necessary for sustained DC1 gene induction in the presence of C. neo antigen at the mRNA and protein levels in vivo, and DCs from infected control mice, which clear C. neo infection, are phenotypically similar to the in vitro TNF-programmed DC1.
Epigenetic modifications of chromatin play an important role in immunological memory-type responses of innate cells. We performed an RNA screening of a large panel of histone and DNA modification enzymes that could be associated with DC1 activation from our in vitro BMDC model and in vivo mouse model ( fig. S5 ). While histone deacetylases (HDACs) were broadly up-regulated during in vivo infection in the TNF-competent animals, TNF-programmed DC1 both in vitro and in vivo featured up-regulation of MLL1, an enzyme responsible for adding methyl groups to H3K4. The trimethylation mark on H3K4 (H3K4me3) is associated with open chromatin and functionally corresponds with stable up-regulation of the gene expression downstream of H3K4me3 promoter regions. Increased H3K4 signature at a large group of specific gene promoter regions can be detected as a global increase in H3K4me3 signature in monocytes, which is a hallmark and proposed mechanism of trained innate immunity (9) . To determine whether endogenous TNF contributes to changes in H3K4me3 signature in DCs in vivo, we analyzed the level of H3K4me3 within DC by flow cytometry: DCs from infected control mice had the elevated H3K4me3 signature relative to DCs from infected anti-TNF mice ( fig. S6 ), providing a clue that the H3K4me3 signatures could be differentially affected by the infection process in the presence or absence of TNF signaling.
To examine the impact of endogenous TNF on epigenetic regulation of pulmonary DC during C. neo infection, specifically the H3K4me3 landscape, we performed chromatin immunoprecipitation sequencing (ChIP-seq) on the infected mice (day 14) with or without TNF depletion. DC isolated from C. neo-infected, anti-TNF-treated mice showed less pronounced coverage in H3K4me3 than that from C. neo-infected control mice (Fig. 3A) . A principal components analysis of lung DC H3K4me3 normalized read counts consistently showed infected control, and TNF-depleted groups formed sepa-rate clusters along principal components 1 and 2 ( Fig. 3B ), providing evidence of their distinct H3K4me3 patterns. Subsequent analysis of H3K4me3 on or around known genes based on peak occupancy between each experimental group (detailed in Supplemental file 1 C.neo H3K4me3 Peaks.xlsx) revealed enrichment of both unique and shared H3K4me3 peaks in DC from the C. neo and C. neo anti-TNF samples. These genes with differential H3K4me3 enrichment peaks are listed in Supplemental file S2 (52D Infected Unique and Shared Peaks.xlsx). Gene ontology pathways with different H3K4me3 occupancy in C. neo and C. neo anti-TNF samples were primarily involved in basic cell survival and function, including cellular metabolism, response to stress, cell cycle, and transcription (Supplemental file S3 52D Infected Gene Ontology.xlsx). We found that C. neo samples had different peak occupancy in H3K4me3 at the promoter site or inside DC1 genes, including NOS2 and IL12B, when compared to C. neo anti-TNF samples (Fig. 3 , C and D). To solidify and quantify these findings, we next performed ChIP-PCR and showed that DCs from infected control mice had significant enrichment of H3K4me3 at iNOS and IL-12b gene regions, while anti-TNF mice showed only a background levels of H3K4me3 at those genes at 14 dpi ( Fig. 3 , E and F). In contrast, the -actin gene showed similar levels of H3K4me3 in control and anti-TNF mice ( Fig. 3G ). Collectively, our data suggest that TNF is required for epigenetic stabilization of key DC1 genes in vivo during IFI.
TNF produces epigenetically stabilized DC1 associated with MLL1-mediated H3K4 methylation
We next assessed whether our in vitro model of TNF-mediated DC1 programming, in addition to being phenotypically similar to DCs from TNF-competent mice, also had a similar epigenetic makeup. Analysis of the broad H3K4me3 signature of DC1, DC2, and TNFprogrammed DC1 revealed that in the absence of TNF, both DC1 and DC2 had lower global H3K4me3 signature, but TNF-programmed DC1 had a higher H3K4me3 signature, even with secondary IL-4 challenge ( Fig. 4 , A to C). TNF treatment alone did not increase H3K4me3 signature (not shown).
We next asked whether the high H3K4me3 signature showed preferential association of key DC1 gene promoters with the activating histone mark H3K4me3. We performed ChIP-qPCR to assess the association between H3K4me3 and the promoter regions of iNOS and IL-12b in DC1, DC2, and TNF-programmed DC1. TNFprogrammed DC1 had increased association of both iNOS and IL-12b promoters with H3K4me3, while DC1 and DC2 did not (Fig. 4 
, D and E).
Given the increased H3K4me3 global signature and association with DC1 gene promoters in TNF-programmed DC1, we next screened the expression of methyltransferases and demethylases acting on H3K4. MLL1, which adds activating methyl groups to H3K4, was uniquely up-regulated in TNF-treated DC1s, unlike non-TNF-treated DC1 or in DC2 ( Fig. 4F ). Moreover, TNF alone or IFN alone was insufficient to induce MLL1 expression; only the combination of TNF and IFN induced MLL1 expression over baseline ( Fig. 4G ). We also studied whether the presence or absence of TNF affected the level of MLL1 expression in infected mice in vivo. Consistent with the in vitro data, DC from infected control mice maintained MLL1 expression, while anti-TNF mice had suppressed MLL1 expression ( Fig. 4 , H and I). Last, to test whether MLL1mediated H3K4 methylation (dependent on the enzymatic activity of MLL1) was required for TNF-mediated DC stabilization, we inhibited MLL1 during the TNF programming phase using the specific small-molecule inhibitor of MLL1, MM102 (33) . TNFprogrammed DC1s had uniformly high iNOS and IL-12b expression, regardless of IL-4 challenge in the absence of MM102 (Fig. 4 , J and K). However, in the presence of MM102, IL-4 challenge decreased iNOS and IL-12b, restoring DC plasticity to TNF-programmed DC1s (Fig. 4 , J and K). Thus, our data indicate that TNF-treated DC1 stability depends on MLL1-mediated H3K4 methylation.
TNF-programmed DC1s promote T H 1 immunity in vivo
To determine whether sustained DC1 programming was linked to the maintenance of protective T H 1/T H 17 immune responses during C. neo infection, we compared the polarization of pulmonary CD4 T cells in control and TNF mice. Significantly more CD4 T cells from control mice made IFN and IL-17, while fewer made IL-5 at 14 dpi relative to CD4 T cells from TNF mice ( Fig. 5 , A to C). To mechanistically link the T H 1/T H 17 phenotype with stable TNF-programmed DC1s in infected mice, we tested whether TNF-programmed DC1s were sufficient to rescue T H 1 polarization in TNF-depleted mice relative to transfer of non-TNF-programmed DC1s. As detailed in Fig. 5D , all mice were TNF-depleted and infected on day 0 and then received intravenous transfer of either 1 million conventional DC1s (no TNF) or TNF-programmed DC1s at 1 and 8 dpi. Transfer of non-TNF-programmed conventional DC1s was insufficient to induce T H 1 polarization in C. neo-infected TNF mice, resulting in low numbers of IFN-producing CD4 T cells and higher numbers of IL-5-producing CD4 T cells compared to mice receiving transfer of TNF-programmed DC1 (Fig. 5 , D to F). Transfer of TNFprogrammed DC1s significantly increased IFN-producing CD4 T cells and decreased IL-5-producing CD4 T cells in TNF mice at 14 dpi (Fig. 5 , E and F). Thus, TNF-programmed DC1s, but not conventional DC1s, can enhance T H 1 polarization in C. neo-infected TNF mice and overcome the effects of early TNF depletion. TNF is required for DC1 preprogramming in the BM of C. neo-infected mice We expected that many DCs would be replaced during the 4-week duration of cryptococcal clearance, yet they maintained the protective DC1 phenotype. Thus, we hypothesized that myeloid DC precursors in the BM of C. neo-infected mice may become preprogrammed by TNF for future differentiation into stable DC1s. TNF depletion did not appreciably change the frequencies of total BM cells, general myeloid precursor cells (MPCs) (CD3 − /GR1 − /CD11b − /B220 − /Ter119 − / SCA1 − /Flt3 + /CD115 + ), or specific pre-DCs (CD3 − /GR1 − /CD11b − / B220 − /Ter119 − /SCA1 − /Flt3 + /CD115 + /c-kit − ) in the presence or absence of infection ( fig. S7 ). However, immunofluorescence microscopy of magnetically sorted pre-DCs revealed statistically significant increases in nuclear MLL1 and H3K4me3 intensity in pre-DCs of control mice relative to TNF mice (Fig. 6A ). Intranuclear flow cytometry staining revealed a higher frequency of MPCs in infected control mice displaying elevated H3K4me3 signature relative to those MPCs from TNF mice (Fig. 6B ). This indicated that the enhanced H3K4me3 signature found in pulmonary myeloid cells during C. neo infection was paralleled by similar signatures in DC precursors, supporting the idea that TNF preprograms DC precursors during infection.
To determine whether MPCs from BM during infection were predisposed to DC1 or DC2 polarization before their arrival to the lung, we collected BM from four cohorts of mice: (i) uninfected control mice, (ii) uninfected TNF mice 7 days after TNF depletion, (iii) isotype-treated mice at 7 dpi, and (iv) TNF mice at 7 dpi. BM obtained from each cohort was cultured for 7 days with GM-CSF, treated with IFN in the presence or absence of TNF (programming phase), and then challenged with IL-4 (challenge phase). BMDCs from uninfected control and TNF mice were receptive to TNFmediated programming: Cells treated with IFN up-regulated DC1 marker iNOS, IFN-treated DCs challenged with IL-4 suppressed iNOS, and the addition of TNF to the initial IFN treatment resulted in stable DC1 that resisted IL-4-mediated iNOS suppression (Fig. 6C ). However, DCs from infected control or TNF mice did not respond to TNF programming or IFN or IL-4 challenges regardless of cytokine stimulation. BMDCs matured from infected control mice maintained high expression of DC1 marker iNOS regardless of ex vivo programming or challenge after differentiation into DCs (Fig. 6D, left) , indicating that DCs from the BM of infected mice with intact TNF signaling were preprogrammed for DC1 polarization. In contrast, BMDCs matured from infected TNF mice displayed uniform down-regulation of iNOS regardless of ex vivo programming or challenge after differentiation into DCs (Fig. 6D,  right) , suggesting that the DCs from TNF mice were not prepolarized to DC1 and remained unresponsive to a subsequent DC1-polarizing stimulation.
DISCUSSION
Monoclonal antibody (MAB) therapies targeting central mediators of inflammatory responses, such as TNF, have become a common immunotherapy approach in contemporary clinical practice. Unfortunately, TNF MAB therapy comes at a cost of significantly increased risk for the development of devastating infections (22) (23) (24) 34) . Following our previous work, which established the central role of TNF for the development of protective T H 1 immunity in the relevant model of IFI (7, 25, 26, 35) , here, we defined a previously unknown mechanism by which TNF exerts its profound and lasting effect on host defenses.
We provide evidence that (i) TNF contributes to the generation of a uniquely stable DC1 phenotype, which is resistant to DC2 repolarization; (ii) TNF-stabilized DCs arising during the afferent phase of the immune response are required for generation and sustenance of protective T H 1/T H 17 immunity; (iii) TNF-mediated DC1 stabilization is associated with the H3K4me3 histone modification at promoter regions of several thousand specific genes, including those responsible for type 1 DC polarization; and (iv) histone modification and the downstream changes in DC1 stability are linked to the histone methyltransferase MLL1 activity.
Mononuclear myeloid cells, at least in their naïve stage, are highly plastic, readily changing their phenotype following the environmental cues (36, 37) . Our recent study demonstrated that TNF depletion at the onset of the immune response resulted in permanent alteration of DC phenotype in the lymph nodes that lasts through extended infection with the persistent fungal pathogen C. neo (7) . These findings suggested that TNF-pulsed DC may also undergo a similar type of programming, which required the upstream process to properly direct the immune polarization. Our series of in vitro and in vivo studies now demonstrate directly that TNF is required for generation of programmed DC1 and is crucial for initiating and sustaining T H 1/ T H 17 responses and driving the clearance of IFI.
In vitro, a similar DC1 program could be sufficiently induced by joint DC stimulation with TNF and IFN, but not by either of these cytokines alone, or with TNF with the DC2-polarizing IL-4, which is consistent with the established role of TNF-IFN synergism in generation of T H 1 responses (38) (39) (40) . However, the unique importance of TNF in generation of stable DC1 phenotype is underscored by insufficiency of DC1 generated with IFN alone to improve T H 1 polarization in the context of C. neo infection of TNF-depleted mice. IFN alone rapidly, but only transiently, up-regulates DC1 gene expression, which differs from TNF-stabilized DC1. Our data further show that this DC1 phenotypic stability helps to overcome the effects of both cytokines and C. neo antigen to suppress DC1 phenotype throughout the extended period needed to eliminate C. neo from the infected host. Last, both TNFRI and TNFRII appear to contribute to this TNF-mediated DC1 programming ( fig. S3 ); while TNF is the major player, it is possible that other TNFR ligands (i.e., LT) could potentially be involved.
The acquiescence of phenotypic stability by myeloid cells via epigenetic histone modification has been reported and is an area of intense investigation (2, 18, 41) . The most recognized example is the phenomenon of "trained immunity," when myeloid cells (monocytes and macrophages) acquire properties compatible with immunological memory. As a result, the trained myeloid cells show enhanced cytokine expression and enhanced microbicidal functions upon reexposure to pathogens. Trained immunity shows many parallels with TNF-induced DC1 programming, including enhanced expression of proinflammatory cytokines and a broadly enhanced H3K4me3 signature on a large group of specific gene promoters and enhanced expression of these genes. Innate immune memory has been demonstrated to depend on similar H3K4me3 at proinflammatory gene promoter regions of monocytes during sepsis or upon challenge with LPS (18, (41) (42) (43) , tuberculosis vaccine bacillus Calmette-Guerin (44) (45) (46) (47) (48) (49) , and fungal -glucans (6, 9, 10) . Although our work is the first, as far as we know, to identify that IFN and TNF induce special DC stability, we hypothesize that this effect is very broad and similar response may be found in human primary monocytes and macrophages. It has been recognized for a long time that IFN and TNF co-regulate immune responses in a synergistic manner (38) (39) (40) . Furthermore, the TNF and IFN/STAT1 signaling pathways are shown to play important roles in trained immunity in monocytes, macrophages, and peripheral blood mononuclear cell models (8, 9, 50, 51) . Whether TNF and IFN pathways are required and how they integrate into other essential programs, such as metabolic changes, are currently unclear and warrant future studies.
Unlike classically viewed trained immunity, TNF-mediated DC1 programming occurs at the onset of the immune response and serves to direct the development of primary adaptive host responses. Our in vitro modeling shows that the early presence of TNF during IFNdriven DC1 differentiation induces DC1-associated gene and protein expression profiles, which recapitulate the DC phenotype observed in vivo. The TNF-stabilized DC1 phenotype can no longer be erased by pro-DC2 cytokine challenge or the immunomodulatory antigen. Considering these similarities and differences, it remains to be determined whether TNF-induced DC1 program stabilization represents an initial step in the development of trained DCs or instead these two processes are independent from each other, despite sharing similar epigenetic mechanisms. Regardless, our report shows that epigenetic stabilization is involved (the MLL1 inhibitor studies; Fig. 4 , J and K) in DC1 programming and is a necessary step for the DCs to promote the protective T H 1/T H 17 polarization required for clearance of C. neo and other important IFI and persistent bacterial infections, which can occur as a side effect of anti-TNF immunotherapy (24, (52) (53) (54) .
Our study provides evidence that the molecular basis for stabilizing DC1 programming during TNF treatment involves specific changes in epigenetic enzyme machinery, in particular machinery involved in methylation of H3K4 (a gene expression activating histone modification) in a large group of DC genes, among which is the family of classical activation/DC1 polarization markers. This includes the IL-12B gene, coding for the p40 component of IL-12 and IL-23 cytokines, which promote T H 1 and T H 17 immune polarizations (55) , and NOS2. The increased trimethylation of H3K4me3 residues at critical DC1 gene promoters was linked with more robust MLL1 expression in the presence of TNF in vivo. In vitro, only the combined effect of TNF and IFN enhanced MLL1 expression ( Fig. 4G) , unlike IFN alone, which was sufficient to induce transient DC1 phenotype but insufficient to induce stable DC1 or elevate the H3K4me3 signature in DC (Fig. 3) . This, together with the effects of specific MLL1 inhibitor blocking the effect of TNF on DC1 programming, strongly suggests that MLL1 mechanistically contributes to the development of stable DC1 by generation of H3K4me3 signature DC1 gene promoters. However, involvement of other epigenetic histone or DNA modifications cannot be ruled out.
Our study also opens new questions that still need to be addressed, including additional components of epigenetic machinery that target MLL1 to the specific promoter sites upon TNF stimulation. Furthermore, analysis of other factors contributing to generation of the stable DC1 such as modifications of H3K27 residues and changes in DC metabolic status will be necessary, similar to those documented as a feature of trained immunity (10, 56) . Likewise, broad investigation of histone acetylation patterns during infection in the presence of TNF is necessary, as numerous HDACs were not induced in the TNF in vivo samples during infection. Further studies dissecting the epigenetic landscape of histone modifications, enzymes involved in these process, and metabolic phenotyping of TNF-programmed DC1 are needed to address these points.
One of the commonalities between monocytes and DCs is their BM ontogeny, their relatively rapid turnover in vivo, and de novo differentiation from BM precursors. A similar epigenetic mechanism is used in the developing myeloid cells to stabilize the DC1 phenotype and drive protective T H 1 responses, and the effect is seen at the level of the BM precursor DCs. Corresponding differences in levels of H3K4me3 signatures of the BM pre-DC population harvested from infected control hosts and anti-TNF hosts translate into ex vivo differential maturation of BMDC to stable DC1 cells from the infected control BM donors versus DC2 cells from TNF-treated mice (Fig. 6D) . We demonstrate that the DC1 and DC2 preprogramming can occur in the BM pre-DC population during cryptococcal infection depending on the presence or absence of endogenous TNF. These results are consistent with the recent study showing that modulation of myeloid progenitors in the BM plays an important role conferring lasting memory-type effects on innate cells, although we found no increase in progenitor cell numbers (57) . Together, our data support the idea that preprogramming of myeloid precursors at the BM is an important mechanism providing preprogramming capabilities to innate immune cells with high turnover rate, which, in turn, can support sustenance of protective immune response by sustained generation of DC1.
Clinically, and in direct relation to persistent infections, our work elucidates the cellular and molecular basis behind previously described long-term immune dysregulation resultant from anti-TNF MAB therapies in humans (24, 53, 54, 58, 59) or in experimental models in mice (25, 26) . Anti-TNF MAB therapy, while beneficial for autoimmune disorders, results in a high susceptibility to fungal and mycobacterial infections. We propose that this could be partly due to the absence of proper DC programming when patients initially become infected with opportunistic fungi and bacteria. Last, TNF-induced DC1 programming occurs in vitro both in the absence of any antigen and in the presence of highly immunomodulatory antigen, suggesting broad applicability of our findings to many types of pathogens for which TNF is a necessary part of the immune response. Thus, we propose that DC (and potentially macrophage and monocyte) programming, such as those epigenetically induced by TNF signaling, could be harnessed for immunotherapies. These therapies could be particularly important in situations when these myeloid cells need to tolerate immunomodulatory or suppressive environments (chronic infections or tumors) to trigger and sustain protective immunity. For example, immunostimulatory treatments like IFN are emerging as possible adjunctive treatments for immunoparalysis induced by sepsis (60, 61) .
METHODS
Contact for reagent and resource sharing
Further information and requests for resources and reagents should be directed to and will be fulfilled by M.A.O. (olszewm@umich.edu).
Experimental model and subject details Mice
Six-to 8-week-old female CBA/J mice were obtained from The Jackson Laboratory and housed at the Veterinary Medicine Unit at the Ann Arbor Veterans Administration Hospital under specific pathogenfree conditions. Mice were 8 to 10 weeks old at the time of infection and housed with four mice per cage. At the time of data collection, mice were humanely euthanized by CO 2 inhalation followed by severance of the portal vein. All experiments were approved by the University Committee on the Use and Care of Animals and the Veterans Administration Institutional Animal Care and Use Committee. Cryptococcus neoformans C. neo serotype D strain 52D (American Type Culture Collection 24067) was recovered from 10% glycerol frozen stocks stored at −80°C. Cultures were grown at 37°C in Sabouraud dextrose broth (1% neopeptone and 2% dextrose; Difco, Detroit, MI) on a shaker. When cultures reached mid-log phase growth (day 3), an aliquot of culture was washed in sterile nonpyrogenic saline (Travenol, Deerfield, IL), counted on a hemocytometer, and diluted to 3.3 × 10 5 yeast cells/ml in sterile nonpyrogenic saline.
Intratracheal inoculation of C. neo
Mice were anesthetized with intraperitoneal injection of ketamine/ xylazine (100/6.8 mg/kg body weight) and secured onto a clean foam board. Hair was removed from over the trachea, and skin was sterilized with iodine and ethanol. A small incision was made over the trachea, and the underlying muscle and glands were separated to expose the trachea. A 30-gauge needle was inserted into the trachea, and 30 l [10 4 colony-forming units (CFUs)] of the washed yeast (3.3 × 10 5 yeast cells/ml in sterile nonpyrogenic saline) was injected intratracheally from a 1-ml tuberculin syringe fitted to a stepper pipette. After inoculation, the incision was closed with cyanoacrylate adhesive, and mice were kept warm and monitored during recovery from anesthesia.
Adoptive transfer
At day −7, BMDCs were generated as described below and differentiated over 7 days, and on day 0, the loosely adherent fraction was plated as described above and stimulated for 24 hours with TNF and IFN in combination () to generate TNF-programmed DC1s or with IFN alone () to generate unprogrammed DC1s. On day 0, CBA/J mice were inoculated intratracheally as above with C. neo 52D and TNF-depleted by intraperitoneal injection of TNF-blocking antibody. On day 0, another set of BMDCs was generated and differentiated as described below for 7 days. On day 1, 1 million  DCs or -only DCs in plain phosphate-buffered saline (PBS) were injected intravenously through the retro-orbital route into the C. neo-infected, TNF-depleted mice. On day 7, the loosely adherent fraction of the second set of BMDCs was harvested, plated, and stimulated for 24 hours with  or  alone. On day 8, a second retro-orbital injection of 1 million  or -alone DCs was transferred as described above. Mice were harvested at 14 dpi, and the CD4 T cells were assessed for T H polarization by intracellular flow cytometry.
In vitro experiments
All in vitro experiments were performed with primary BM-derived macrophages from femurs and tibias of female CBA/J mice, unless otherwise specified. Uninfected mice were humanely euthanized, and death was confirmed by exsanguination. Two femurs and two tibias were isolated from each mouse and washed in 70% ethanol, and then epiphyses were removed and marrow was flushed with D20 medium [Dulbecco's modified Eagle's medium + 20% fetal bovine serum, penicillin and streptomycin (1 U/ml; Invitrogen, Grand Island, NY), 1× sodium pyruvate, 1× GlutaMAX, 1× nonessential amino acids, 2-mercaptoethanol, 20 nM GM-CSF] using 26-gauge needles. Cell suspension was filtered through sterile 100-m Nitex. Cells were pelleted, resuspended in D20, and grown in sterile, non-tissue culturetreated 150-mm petri dishes for 7 days. Medium was replenished with D20 on day 3. After 7 days, the loosely adherent fraction was harvested in PBS, pelleted, counted, and plated in non-tissue culturetreated six-well dishes at a concentration of 2 × 10 6 cells per well.
For DC-T cell coculture, BMDCs were generated from C57BL/6 OT-II mice as above and then cultured with freshly isolated splenocytes from OT-II mice for 5 days. For splenocyte isolation, spleens were removed, trimmed of fat and connective tissue, and then ruptured, and cells were dispersed over a sterile 75-m cell strainer. Strainers were flushed with 5 ml of RPMI 1640, and the resulting cells were pelleted and added to the cultures.
For ex vivo BMDC experiments using marrow from infected or uninfected control or TNF-depleted mice, four femurs from each group were isolated and marrow was prepared as above at 7 dpi, taking care to keep each condition separate.
Method details BMDC programming and challenge
For the programming phase, IFN was used at a concentration of 100 ng/ml, TNF was used at a concentration of 20 ng/ml, and cells were incubated for 24 hours. For the challenge phase, programming phase medium was aspirated, wells were washed with sterile PBS, and challenge medium containing IL-4 was used at a concentration of 20 ng/ml, while IFN control-challenge medium was at the same concentration as above. For experiments using HKC, cultures of strain 52D were counted, diluted to 2 × 10 8 CFU/ml, and heat-killed by incubating at 65°C for 6 hours. Heat-killed cultures were added to the BMDCs at a multiplicity of infection of 10 during the programming phase for 24 hours and washed out before the challenge phase. For experiments using MM102 (Tocris, Bristol, UK), the inhibitor of MLL1, it was used at a concentration of 50 M during the programming phase for 24 hours and washed out before challenge. For experiments using TNFRI and/or TNFRII blockade, sterile validated LEAF-purified blocking antibodies for TNFRI and TNFRII were purchased from BioLegend and used at a concentration of 10 g/ml for 24 hours during the programming phase and the challenge phase. For medium-and TNF-only control wells (using the same TNF concentration as above), cells were incubated for 24 hours in their respective medium, washed identically to experimental wells, and further incubated for 24 hours in plain medium. Supernatants for enzyme-linked immunosorbent assay (ELISA) were harvested at this point, and the remaining cells were either lysed in TRIzol for quantitative reverse transcription (qRT)-PCR or detached for flow cytometry.
Experiments using BMDCs from infected and uninfected control and TNF mice were also performed as above.
OT-II cocultures
For OT-II DC-T cell cocultures, DCs were generated as described above and then treated with IFN at a concentration of 100 ng/ml in the presence or absence of TNF at 20 ng/ml and C. neo at a multiplicity of infection of 10. After the programming phase, wells were washed and OT-II CD4 T cells were added at a ratio of four T cells to one DC. Cultures were incubated for 5 days, and then cells were removed and their surface markers and cytokine production were analyzed by flow cytometry.
Serum preparation
Mice were humanely euthanized by CO 2 asphyxiation and then exsanguinated to confirm death. Whole blood was collected in Eppendorf tubes, spun down to consolidate blood, and allowed to rest at room temperature for 20 min. Blood was then incubated at 4°C for 20 min and then centrifuged at 5000 rpm to separate serum from erythrocytes. The top serum layer was collected and frozen at −80°C until ELISA or cytometric bead array for cytokine analysis.
Lung leukocyte isolation
At the time of data collection, lungs were perfused with 3 ml of sterile nonpyrogenic saline, removed, washed in RPMI 1640, and enzymatically dispersed as previously described (62, 63) . Briefly, excised lungs from each mouse were minced with scissors and digested enzymatically at 37°C for 30 min in 5 ml/mouse digestion buffer [RPMI 1640, 5% fetal bovine serum, penicillin and streptomycin (Invitrogen, Grand Island, NY), collagenase A (1 mg/ml; Roche Diagnostics, Indianapolis, IN), and deoxyribonuclease (30 mg/ml; Sigma)]. The cell suspension and tissue fragments were further dispersed by repeated aspiration through the bore of a 10-ml syringe and centrifuged. Erythrocytes in the cell pellets were lysed by the addition of 3 ml of NH 4 Cl buffer [0.829% NH 4 Cl, 0.1% KHCO 3 , and 0.0372% Na 2 EDTA (pH 7.4)] for 3 min, followed by a 10-fold excess of RPMI 1640. Cells were resuspended, and a second cycle of syringe dispersion and filtration through a sterile 100-mm nylon screen (Nitex, Kansas City, MO) was performed. The filtrate was centrifuged for 25 min at 1500g in the presence of 40% Percoll (Sigma-Aldrich) in complete RPMI 1640 [RPMI 1640, 5% fetal bovine serum, penicillin and streptomycin (10 U/ml; Invitrogen, Grand Island, NY), 1× sodium pyruvate, 1× GlutaMAX, 1× nonessential amino acids, 2-mercaptoethanol] with no brake to separate leukocytes from cell debris and epithelial cells. Leukocyte pellets were resuspended in 5 ml of complete RPMI 1640 medium and enumerated on a hemocytometer after dilution in trypan blue (Sigma-Aldrich).
Lung CFU assay
For determination of fungal burden in the lungs, 100 l was removed from the enzymatically dispersed lungs before centrifugation and 10-fold dilutions were plated in duplicate on Sabouraud dextrose agar plates. Colonies were counted after 48 hours of growth at room temperature, and CFU was calculated on a per-organ basis.
Preparation and enumeration of lung leukocytes
Following enzymatic dispersal of the lungs, 50,000 cells were cytospun onto glass slides, fixed, stained with Wright-Giemsa stain, and dried. Monocytes, eosinophils, neutrophils, and lymphocytes were counted as described previously (64) .
Flow cytometry
Enzymatically dispersed lungs were counted and stained extracellularly and then fixed, permeabilized, and stained intracellularly. Briefly, cells were stained with fixable LIVE/DEAD stain (Thermo Fisher Scientific, USA) according to the manufacturer's instructions, washed twice in fluorescence-activated cell sorting (FACS) buffer (Difco Laboratories, Detroit, MI), resuspended in 100 l of staining buffer (FACS buffer with Fc block; BioLegend, San Diego, CA), and incubated for 30 min at 4°C in the dark with labeled antibodies diluted in 100 l of staining buffer. Final antibody concentrations were 1 to 2 g/10 6 cells. Intracellular staining was performed using the FoxP3/ Transcription Factor Staining Buffer Kit from eBioscience (San Diego, CA) according to the manufacturer's instructions. Cells were then run on an LSR II flow cytometer using FACSDiva software (BD Biosciences, San Jose, CA) and analyzed further using FlowJo software (Tree Star, San Carlos, CA).
Gating for lung myeloid cells proceeded as follows: The CD45 + cells were identified, lymphocytes were removed (CD19 + /CD3 + ), neutrophils were removed (Ly6G + /CD11b + ), eosinophils were excluded (SSC high /CD11c int ), and then CD11c + (myeloid cells) or CD11b + / CD11c + (DCs) cells `were analyzed for expression of activation markers. Gating for lung CD4 T cells proceeded as follows: The CD45 + cells were identified, cells were selected on CD3 + , and CD19/CD11b/ CD11c + cells were excluded. T cells were then gated on CD4 versus CD8 expression, and the CD4 single-positive population was analyzed for surface activation marker expression and intracellular expression of T H polarization cytokines. Intracellular staining was performed using the FoxP3/Transcription Factor Staining Buffer Kit from eBioscience (San Diego, CA). For specific antibodies, see each respective Methods section.
For intranuclear flow cytometry of H3K4me3, purified H3K4me3 (catalog no. 61379) was obtained from Active Motif (Carlsbad, CA) and the PE/Cy7 Conjugation Kit (Abcam, Cambridge, United Kingdom) was used to attach the Phycoerythrin (PE)/Cy7 fluorophore to the antibody according to the manufacturer's protocol. Intranuclear staining was performed using the Foxp3/Transcription Factor Staining Buffer Set (eBioscience, San Diego, CA) following the manufacturer's protocol. Antibodies used are listed in the "Key resources" table. Multiplex ELISA Cytokine levels were analyzed by LEGENDplex Th Cytokine and Inflammation panels. Serum from whole blood and standard curve was diluted in Matrix C reagent and stained as per the manufacturer's instructions (BioLegend, San Diego, CA). Bead-antibody-protein complexes were fixed and run on an LSR II flow cytometer using FACSDiva acquisition software. Results were analyzed using software included with LEGENDplex kits. Quantitative polymerase chain reaction Cells were spun down and directly resuspended in 1 ml of TRIzol reagent (Life Technologies Inc., Gaithersburg, MD) in polypropylene tubes. Samples were allowed to incubate at room temperature, and 200 l of chloroform per 1 ml of TRIzol was added to them. Samples were spun at 10,000 rpm for 15 min, the aqueous phase was transferred into fresh tubes, and equal volumes of isopropanol were added. Samples were then incubated at −20°C for 90 min to precipitate the RNA and centrifuged again as described above. Pellets were washed with 1 ml of 70% ethanol and centrifuged. RNA was resuspended in nuclease-free water (Ambion). The yield and purity of the RNA were determined spectrophotometrically at 260 and 280 nm. Complementary DNA (cDNA) was synthesized using QuantiTect Reverse Transcription Kit (Qiagen) using 1 g of RNA according to the manufacturer's instructions. For CD4 cells, T H differentiation qPCR arrays with 96 genes per sample were purchased from SABiosciences (Qiagen) and used initially, while individual qPCRs were performed later to confirm and expand analyzed genes. For CD11c cells, custom qPCR arrays with 48 genes per sample were used initially, while individual qPCRs were performed later to confirm and expand analyzed genes. For individual qRT-PCRs, cDNA was quantified with SYBR Green-based detection using an MX3000P system (Stratagene, La Jolla, CA) according to the manufacturer's protocols. Forty cycles of PCR (94°C for 15 s, followed by 60°C for 30 s and 72°C for 30 s) were performed on a cDNA template. Primer sequences can be found in table S1. The mRNA levels were normalized to 18S mRNA levels. Primer sequences can be found in the "Key resources" table.
ChIP and qPCR
ChIP was performed using the protocol from the laboratory of Y. Dou at the Department of Pathology, University of Michigan. Briefly, magnetically separated CD11c + cells were isolated from the lungs of mice at 14 dpi and fixed in formaldehyde at a final concentration of 1%. The fixation was stopped with 5 M glycine, cells were pelleted, the supernatant was aspirated, and pellets were frozen at −80°C until 25 × 10 6 to 30 × 10 6 cells per treatment were accumulated. Cells were thawed and lysed in SDS lysis buffer [1% SDS, 10 mM EDTA, 50 mM tris (pH 8.0), 1× cOmplete protease inhibitor cocktail] and homogenized by aspiration through a 27-gauge needle twice. Cells were sonicated on ice in a Bioruptor using the highest setting for 15 min with 30 s on/30 s off cycles. Sonication efficiency and chromatin shearing were assessed by running a small aliquot of sample on 1% agarose gel before proceeding. Reactions were centrifuged to pellet debris, and supernatant was removed and diluted in ChIP dilution buffer [0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM tris-HCl (pH 7.5), 167 mM NaCl, 1× cOmplete protease inhibitor cocktail]. Input fraction (1%) was removed here, and then the diluted lysate was aliquoted to Eppendorf tubes and antibodies were added at a concentration of 2.5 g. Reactions were incubated overnight (65) . Briefly, after sorting, the cells were placed in 20 l of nuclear isolation buffer and were frozen at −80°C. The samples then underwent a micrococcal nuclease digestion (7.5 min at 21°C for 10,000 to 20,000 cells and 5 min at 37°C for 21,000 to 200,000 cells), and 10% of the sample was then removed and processed as input. The remaining samples were incubated overnight with 0.5 to 1 g of anti-H3K4me3 (Abcam, ab8580) in the presence of protein A:protein G 1:1 dynabeads. The samples were then washed and eluted. The DNA was extracted using phenol:chloroform:isoamyl alcohol and were precipitated overnight using linear polyacrylamide. The samples were washed in 70% ethanol, and library construction was performed as previously described (65) . After library preparation, the samples were pooled in equimolar concentrations and sequenced on an Illumina HiSeq 2500 platform (single-end 50-nucleotide reads). Sample quality was assessed using ChIPQC (66) . Adapter sequences were trimmed from the raw sequencing reads using Trimmomatic (67) . Raw reads were aligned to the GRCm38 Mus musculus genome using HISAT2 version 2.1.0 using the single-end option (68) . Peaks were called against input using MACS2 version 2. FACSDiva was used to compare peaks between different experimental groups (70) . As expected, most of the H3K4me3 peaks (up to 70%) were localized in the strictly defined promoter region, and the H3K4me3 peak distribution plots yielded curves consistent with those previously reported ( fig. S8 ) (71, 72) . Peaks were annotated, and gene ontology terms were identified using ChIPpeakAnno (73) . Input background was subtracted from the H3K4me3 files with MACS2 using the -subtract option. The Integrative Genomics Viewer was used for data visualization (www. broadinstitute.org/igv). The datasets used in this manuscript are available in the Gene Expression Omnibus repository under GSE118543.
Fluorescence microscopy
CD11b + pre-DCs were isolated from the BM of isotype or TNFdepleted infected and control mice by magnetic bead separation as described above according to the manufacturer's protocol. Cells were washed and counted, and then 20,000 cells were cytospun onto charged glass microscope slides, fixed, stained with primary antibodies against H3K4me3 (Active Motif, Carlsbad, CA) and Fizz1 (R&D Systems, Minneapolis, MN) or control immunoglobulin G (IgG) (R&D Systems), then stained using anti-rabbit Alexa Fluor 594 or anti-goat Alexa Fluor 488 secondary antibodies, and mounted with VECTASHIELD mounting medium plus 4′,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlingame, CA). Slides were visualized by confocal microscopy using a spinning disk confocal microscope (Olympus America Inc., Center Valley, PA) with a digital chargecoupled device camera (Hamamatsu Photonics, Hamamatsu, Japan) for image capture and an arc lamp illumination source providing excitation wavelengths of 350 to 700 nm and three-color emission analyses. The acquired digital images were processed and analyzed using Stereo Investigator software version 9 (MBF Bioscience, Williston, VT).
Quantification and statistical analysis
All values are reported as means ± SEM. Continuous ratio scale data were evaluated by unpaired Student's t test (for comparison between two samples) or analysis of variance (ANOVA) (for multiple comparisons) with post hoc analysis using Student's t test with Bonferroni adjustments. Nonparametric analysis was performed using the Kruskal-Wallis, Kolmogorov-Smirnov, or Mann-Whitney tests. Statistical calculations were performed using GraphPad Prism version 6.0 (GraphPad Software, San Diego, CA). Statistical difference was accepted at P < 0.05, symbols are explained in the figure legend, and descriptions of the samples compared are included in the figure legend. For each experiment, n is indicated in the figure legend and refers to biological replicates, often either mice or individual wells of an experiment. Where applicable, the number of repeated experiments is indicated in the figure legend.
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